Gastric, cholecyst, biliary tract, pancreatic, colonic, rectal, pulmonary & ovarian cancer; hepatocarcinoma, mastocarcinoma, hysterocarcinoma in concomitant use w/ other anticancer agents. Induction of clinical remission &/or maintenance therapy in acute myeloid leukemia, acute lymphoblastic & non-lymphoblastic leukemias, blast crisis of chronic myeloid leukemia & diffuse histiocytic lymphomas.